Has John Martin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,618 in general payments to John Martin, MD across 106 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Martin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Martin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Martin, MD

Pain Medicine · Lafayette, LANPI 1245227255

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Abbott at 48.3% of the total. Reporting peaked in 2019 at $805 and has fallen 84.2% since, to $127 in 2025. That places this record below the midpoint for pain medicine clinicians in LA, where the typical reported total is $3,650.

$2,618in general payments, 2019–2025

Across 106 payments — averaging $24.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$1K
Medtronic$381
Nevro Corp.$296
Boston Scientific$138
Saluda Medical Americas, Inc.$103
Valinor Pharma, LLC$65
plus $373 from 13 others

What the payments were for

Food & beverage$2,618100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	35	$1,263
Medtronic(2 entities)	25	$381
Nevro Corp.	15	$296
Boston Scientific	5	$138
Saluda Medical Americas, Inc.	1	$103
Valinor Pharma, LLC	4	$65
Stryker	2	$55
Assertio Therapeutics, Inc.	3	$37
Arbor Pharmaceuticals, Inc.	3	$36
Pfizer	2	$30
Globus Medical	1	$30
Avanos Medical	1	$29
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$29
Stimwave Technologies Incorporated	2	$28
Pacira Pharmaceuticals Incorporated	1	$26
Azurity Pharmaceuticals, Inc.	1	$21
Spinal Simplicity, LLC	1	$18
Collegium Pharmaceutical, Inc.	1	$17
Acacia Pharma Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Proclaim Family of SCS IPGs$286
Proclaim IPG$146
ETERNA$141
Senza Spinal Cord Stimulation System$111
Evoke$103

How this compares

$2,618 in reported general payments places this provider in the 40th percentile of 97 pain medicine providers in Louisiana.

See all pain medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024

$75,630

Medicare patients

167

Services billed

867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Potassium	46	$14,398
MovantikNaloxegol Oxalate	14	$4,792
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	238	$4,347
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	195	$2,857
Gabapentin	255	$2,318
Duloxetine Hcl	159	$1,373
Celecoxib	37	$1,308
Morphine Sulfate ErMorphine Sulfate	24	$1,077
Tizanidine Hcl	120	$963
Pregabalin	105	$854
Diclofenac Sodium	50	$807
Methadone Hcl	71	$612
Doxepin Hcl	11	$497
Trazodone Hcl	46	$392
Methylprednisolone	42	$290

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lafayette

James RabalaisLafayette$10K
Joseph GillespieLafayette$8K
John FrugeLafayette$4K
Thomas MyersMandeville$118K
Alan KayeNew Orleans$76K
Derrick DeanTerrytown$68K
Hazem EissaNew Orleans$50K
Robert OwensNew Orleans$47K
Gassan ChaibanLake Charles$30K
Yashar EshraghiNew Orleans$22K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →